Francis Jay Mussai (Francis Mussai)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Acute Lymphoblastic Leukemia

Nitric Oxide Synthase

Top Venues

International journal of cancer

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin M Rattigan, Martha M Zarou, Zuzana Brabcova, Bodhayan Prasad, Désirée Zerbst, Daniele Sarnello, Eric R Kalkman, Angela Ianniciello, Mary T Scott, Karen Dunn, Engy Shokry, David Sumpton, Mhairi Copland, Saverio Tardito, Johan Vande Voorde, Francis Jay Mussai, Paul Cheng, G Vignir Helgason
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells. EMBO reports (2023)
Ebtehag Maneta, Livingstone Fultang, Jemma Taylor, Matthew Richard Pugh, William Jenkinson, Graham Anderson, Arri Coomarasamy, Mark D Kilby, David M Lissauer, Francis Jay Mussai, Carmela De Santo
G-CSF induces CD15 + CD14 + cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment. Clinical & translational immunology 11 (5) (2022)
Silvia Panetti, Nicola Jane McJannett, Livingstone Fultang, Sarah Booth, Luciana Gneo, Ugo Scarpa, Charles Smith, Ashley Vardon, Lisa A Vettore, Celina M Whalley, Yi Pan, Csilla Varnai, Hitoshi Endou, Jonathan P Barlow, Daniel A Tennant, Andrew D Beggs, Francis Jay Mussai, Carmela De Santo
Engineering amino acid uptake or catabolism promotes CAR-T cell adaption to the tumour environment. Blood advances (2022)
Eleanor Bishop, Monika Dimitrova, Alexander Froggatt, Maria Estevez-Cebrero, Lisa C D Storer, Francis Jay Mussai, Simon M L Paine, Richard G Grundy, Madhumita Dandapani
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion. BioMed research international 2022 (2022)
Silvia Panetti, Nicola Jane McJannett, Livingstone Fultang, Sarah Booth, Luciana Gneo, Ugo Scarpa, Charles Smith, Ashley Vardon, Lisa A Vettore, Celina M Whalley, Yi Pan, Csilla Varnai, Hitoshi Endou, Jonathan P Barlow, Daniel A Tennant, Andrew D Beggs, Francis Jay Mussai, Carmela De Santo
Engineering amino acid uptake or catabolism promotes CAR-T cell adaption to the tumour environment. Blood advances (2022)
Francis Jay Mussai, Carmela De Santo, Paul Cheng, Ian F Thomas, Cono Ariti, Laura Upton, Ugo Scarpa, Victoria Stavrou, Mia Sydenham, Alan K Burnett, Steven K Knapper, Priyanka Mehta, Mary Frances Frances McMullin, Mhairi Copland, Nigel H Russell, Mike Dennis
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial. British journal of haematology (2022)
Francis Jay Mussai, Rachel Wheat, Evgenia Sarrou, Sarah Booth, Victoria Stavrou, Livingstone Fultang, Tracey Perry, Pamela Kearns, Paul Cheng, Karen Keeshan, Charles Craddock, Carmela De Santo
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia. International journal of cancer 145 (8) (2019)
Carmela De Santo, Paul Cheng, Andrew Beggs, Sharon Egan, Alberto Bessudo, Francis Jay Mussai
Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma. Journal of hematology & oncology 11 (1) (2018)
Carmela De Santo, Sarah Booth, Ashley Vardon, Antony Cousins, Vanessa Tubb, Tracey Perry, Boris Noyvert, Andrew Beggs, Margaret Ng, Christina Halsey, Pamela Kearns, Paul Cheng, Francis Jay Mussai
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100. International journal of cancer 142 (7) (2017)